Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Consumer Defensive
  3. NASDAQ
  4. SGRX

Market Cap: $1.34M

SI

Sangrix Inc.

SGRX
NASDAQUSD
Purchase SGRX
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin0.00%
EBITDA Margin-53.06%
EBIT Margin-53.06%
Pre-tax Margin-258.01%
Net Profit Margin-259.55%
Earnings Yield-22.12%
Valuation Multiples
Price / Book-0.42
Price / Sales34.03
Price / Earnings-0.02
PEG-0.00
Forward PEG-0.00
EV / Sales387.20
EV / EBITDA-7.30
EV / Operating Cash Flow-3.66
EV / Free Cash Flow0.00
Price / Free Cash Flow0.00
Price / Operating Cash Flow-0.11
Cash Flow & Capital
Free Cash Flow / Share$0
Operating Cash Flow / Share-$15.14
Free Cash Flow Yield0.00%
Capex / Revenue105.71%
Capex / Operating Cash Flow-100.00%
Capex / Depreciation0.00
Stock Compensation / Revenue0.00%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio44.93
Quick Ratio44.93
Cash Ratio1.71
Debt / Assets1.12
Debt / Capital1.08
Debt / Equity-13.15
Long-Term Debt / Capital1.08
Debt / Market Cap10.74%
Net Debt / EBITDA-6.66
Solvency Ratio-0.70
Financial Leverage-11.76
Efficiency & Working Capital
Asset Turnover0.00
Fixed Asset Turnover0.00
Inventory Turnover0.00
Receivables Turnover0.01
Payables Turnover0.00
Days Sales Outstanding28,000.7
Days Inventory Outstanding0
Days Payables Outstanding0
Operating Cycle28,000.7
Cash Conversion Cycle28,000.7
Working Capital Turnover0.01
Returns & Quality
Return on Equity-7.32%
Return on Assets-79.39%
Return on Invested Capital-16.59%
ROCE-16.59%
Return on Tangible Assets-79.39%
Operating Return on Assets-25.48%
Income Quality0.11
Tax Burden1.01
Interest Burden4.86
Balance Sheet & Intrinsic Metrics
Enterprise Value$15.29M
Invested Capital$12.43M
Working Capital$12.43M
Tangible Asset Value$-1.8M
Net Current Asset Value$-2M
Graham Net-Net-$13.36
Book Value / Share-$6.54
Tangible Book Value / Share-$6.54
Cash / Share$31.76
Financial Health Scores
Piotroski Score3
Altman Z-Score-12.33
Revenue$39.5K
EBIT$-7.75M
Market Cap$1.35M
Working Capital$12.43M
Retained Earnings$-106.65M
Total Assets$12.91M
Total Liabilities$14.72M